Demethoxycapillarisin (6-Demethoxycapillarisin) inhibits PEPCK mRNA levels ( IC 50 : 43 μM) by activation of the PI3K pathway. Demethoxycapillarisin decreases glucose production.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > PEPCK
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。